We summarise a recent article, published in the Journal of Racial and Ethnic Health Disparities, that explored access to digital […]
A recent perspective, published in npj Digital Medicine, explores digital health solutions and the current challenges in undertaking digital health […]
Three Digital Health R&D leaders at AstraZeneca outlined in a recent post how the organisation is harnessing data, analytics and […]
Boston, 9th June 2020: The Pistoia Alliance launches a new project to help life sciences and healthcare realize the value […]
A recent study evaluates the impact of a digital therapeutic for opioid use disorder on health utilities and overall costs. […]
We summarise a recent article, published in npj Digital Medicine, that characterised the current pipeline of digital therapeutics and explored […]
The costs of drug R&D are rising. The ongoing COVID-19 has been a catalyst towards digitisation for many companies. Simultaneously, […]
A recent debate article, published in BMC Geriatrics, has explored whether artificial intelligence (AI) health monitoring may be a suitable […]
The UK’s National Institute for Health and Care Excellence (NICE) and six other global leaders, have announced a global initiative […]
Back in June of last year at the Viva Tech event in Paris, Vas Narasimhan, CEO of Novartis, took to […]